Google-backed AI drug discovery startup Isomorphic Labs delays clinical trial timeline

Core Insights - Isomorphic Labs, a company utilizing artificial intelligence for drug discovery, anticipates initiating its first clinical trials by the end of 2026 [1] Company Overview - The founder and CEO of Isomorphic Labs, Demis Hassabis, provided insights into the company's timeline for clinical trials [1]